Activation of p53 might down-regulate the PIK3CA/Akt signalling as indirectly evidenced by association of PIK3CA gene amplification with p53 mutations in ovarian carcinoma [7], [9]. This evidence concerns the gene AKT1 and ovarian carcinoma.